Evidence map›Paper›PMID 33138851›Full record

ReviewBiology direct2020

Mini-review: advances in 3D bioprinting of vascularized constructs.

Lorenzo Bova, Fabrizio Billi, Elisa Cimetta

Abstract readReview
In one paragraph

Review in Biology direct, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. The crisscross between p53 and metabolism in cancer.Acta biochimica et biophysica Sinica · 2023
    Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lorenzo BovaDepartment of Industrial Engineering (DII), University of Padua, Via Marzolo 9, 35131, Padova, Italy.
Fabrizio BilliUCLA Department of Orthopaedic Surgery, David Geffen School of Medicine, Los Angeles, CA, USA. f.billi@ucla.edu.
Elisa CimettaDepartment of Industrial Engineering (DII), University of Padua, Via Marzolo 9, 35131, Padova, Italy. elisa.cimetta@unipd.it.ORCID 0000-0002-8632-3999

Funding

European Research Council ERC-StG UERI17Università degli Studi di Padova CIME_SID16_01
6 · The paper itself

Abstract

3D in vitro constructs have gained more and more relevance in tissue engineering and in cancer-modeling. In recent years, with the development of thicker and more physiologically relevant tissue patches, the integration of a vascular network has become pivotal, both for sustaining the construct in vitro and to help the integration with the host tissue once implanted. Since 3D bioprinting is rising to be one of the most versatile methods to create vascularized constructs, we here briefly review the most promising advances in bioprinting techniques.

Indexed as

BioprintingHumansPrinting, Three-DimensionalTissue Engineering3D modelsBioprintingVascularization

Identifiers

PMID33138851
PMCPMC7607663

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.